1 active not recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow David Palma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. Palliative Radiotherapy, Chemotherapy, Hormone therapy - Metastatic Tumor | Phase 3 | Recruiting | David Palma | 180 | 2023-10-06 | 2025-12-31 |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors Palliative Radiation, Chemotherapy, Immunotherapy - Metastatic Tumors | Phase 3 | Active not recruiting | David Palma | 204 | 2019-02-22 | 2026-09-30 |
Drug Therapy (2) · Immunotherapy (2) · Observation (2) · Hormones (1) · Radiofrequency Therapy (1) · Surgical Procedures, Operative (1)
Canada (2) · Switzerland (2) · Australia (1) · Netherlands (1) · United Kingdom (1)
Robert Olson, MD (1) · Stephen Harrow, MB ChB (1) · Suresh Senan, MRCP, FRCR (1)